PubRank

Christoph Pechlaner

Author PubWeight™ 25.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Disturbances of electrolytes and blood chemistry in acute alcohol intoxication. Wien Klin Wochenschr 2005 1.47
2 A funny patient. J R Soc Med 2007 1.06
3 Dietary poisoning with Veratrum album--a report of two cases. Wien Klin Wochenschr 2005 1.02
4 Comparison of image quality and radiation dose of different pulmonary CTA protocols on a 128-slice CT: high-pitch dual source CT, dual energy CT and conventional spiral CT. Eur Radiol 2011 0.93
5 Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscitation 2004 0.84
6 The smoker's paradox and the real risk of smoking. Eur J Epidemiol 2005 0.79
7 Problematic drugs in elderly patients presenting to a European emergency room. Eur J Intern Med 2003 0.79
8 Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department. Clin Chem 2008 0.78
9 Quality of health care delivered to adults in the United States. N Engl J Med 2003 0.78
10 Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia. Blood Purif 2014 0.77
11 Psychiatric disorders and the ICU: gaps and opportunities. Intensive Care Med 2008 0.77
12 Emergency correction of coagulation before major surgery in two elderly patients on oral anticoagulation. Thromb J 2007 0.76
13 Anticoagulation for atrial fibrillation: underuse? Am J Med 2011 0.76
14 Thrombolytic therapy vs angioplasty in acute myocardial infarction. JAMA 2002 0.75
15 The RITA 3 trial. Lancet 2002 0.75
16 Enoxaparin vs unfractionated heparin in acute coronary syndrome. JAMA 2004 0.75
17 Patient outcome of invasive experiments. Am J Respir Crit Care Med 2004 0.75
18 Statins and sepsis. Lancet 2006 0.75
19 Coated central venous catheters: mortality, illness severity? Crit Care Med 2011 0.75
20 The CHARM programme. Lancet 2003 0.75
21 Roflumilast for chronic obstructive pulmonary disease. Lancet 2005 0.75
22 Cetuximab plus radiotherapy for head and neck cancer. N Engl J Med 2006 0.75
23 Fondaparinux in patients with ST-segment elevation myocardial infarction. JAMA 2006 0.75
24 Heparin in sepsis treatment. Lancet 2007 0.75
25 Anticoagulant-related bleeding risk in older persons: unfounded fears? Arch Intern Med 2004 0.75
26 Antiphospholipid testing and outcome. Arch Intern Med 2004 0.75
27 Ranolazine as add-on therapy for patients with severe chronic angina. JAMA 2004 0.75
28 NEOPAIN: a question of survival. Lancet 2004 0.75
29 Adverse events in diabetes drug trial. Lancet 2009 0.75
30 Comments on the MRC/BHF Heart Protection Study. Lancet 2003 0.75
31 Patients with high-risk acute myocardial infarction randomized to one of two treatment strategies: delay and eligibility questions. J Am Coll Cardiol 2003 0.75
32 Antibacterial prophylaxis in patients with cancer and neutropenia. N Engl J Med 2006 0.75
33 Dabigatran versus enoxaparin after total hip replacement. Lancet 2007 0.75
34 Prevention of postoperative nausea and vomiting. N Engl J Med 2004 0.75
35 Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern. Haematologica 2008 0.75
36 Sweet heart block. Circulation 2008 0.75
37 Antiphospholipid syndrome. What benefit has the label? BMJ 2010 0.75
38 A hidden cause of angina pectoris: when ABG analysis is the only helpful diagnostic tool. Int J Cardiol 2005 0.75